Error loading player: No playable sources found
4210
Barry Marshall (Nobel Laureate 2005) and Adrienne Marshall Lecture: Latest Advances and Challenges in Helicobacter pylori Screening and Eradication
Date
May 5, 2025
This product is not available for individual purchase, but it is available as part of the following products:
Don't miss the opportunity to access the latest research and discoveries in the field of digestive diseases. DDW On Demand is a valuable and convenient way to enhance your knowledge and skills in digestive disease care…
Society: AGA
Chronic Helicobacter pylori (HP) infection is the leading cause of gastric cancer and other adverse outcomes such as peptic ulcer disease. Emerging antibiotic resistance poses a substantial challenge against effective eradication of this organism. This session has two objectives: 1) to evaluate the efficacy of population-based HP screening in reducing gastric cancer incidence globally; 2) to summarize the latest evidence on optimize screening strategies and eradication regimens.
Chronic Helicobacter pylori (HP) infection is the leading cause of gastric cancer and other adverse outcomes such as peptic ulcer disease. Emerging antibiotic resistance poses a substantial challenge against effective eradication of this organism. This session has two objectives: 1) to evaluate the efficacy of population-based HP screening in reducing gastric cancer incidence globally; 2) to summarize the latest evidence on optimize screening strategies and eradication regimens.
Moderators
Brown University
University of Hong Kong Li Ka Shing Faculty of Medicine
Related Products
